Recombinant Capital

Cortellis Deals Intelligence is a biopharma deals intelligence platform designed to assist life sciences companies in evaluating, negotiating, and executing successful partnerships, licensing, and M&A transactions. It provides comprehensive insights into biopharma partnerships and M&A activity, enabling teams to conduct informed deal analysis and n... egotiate stronger outcomes. The platform is utilized by business development and licensing teams across biotech and pharmaceutical companies, offering robust data on deal terms, contracts, and predictive analytics. By leveraging this intelligence, organizations can optimize deal decisions, manage risks, and maximize returns on investment.Read More